Skip to main content


  • Poster presentation
  • Open Access

Preliminary assessment of ShearWave™ elastography features in predicting breast lesion malignancy

  • 1,
  • 2,
  • 2,
  • 3,
  • 4,
  • 5,
  • 6,
  • 7,
  • 1, 8,
  • 9,
  • 10,
  • 10, 11 and
  • 10, 12
Breast Cancer Research201012 (Suppl 3) :P10

  • Published:


  • Breast Lesion
  • Breast Masse
  • Tissue Stiffness
  • Local Quantification
  • Specificity Score


ShearWave™ elastography (SWE) provides a quantitative measurement of tissue stiffness with high spatial resolution and may improve characterization of breast masses. The goal of this study was to evaluate the reproducibility of SWE and the impact of adding SWE features to the BI-RADS classification of breast masses from the first 1,000 cases in a prospective multicenter trial.


SWE studies were performed on a prototype of the Aixplorer system (Supersonic Imagine, Aix-en-Provence, France). A subset of 192 breast lesions (42.71% malignant) was analyzed. Reproducibility of SWE images and measurements was assessed; logistic regression analysis was performed to predict the pathology findings. SWE features were added to the ultrasound BI-RADS to generate models that were challenged by comparing the areas under the ROC curves (Az), and the sensitivity and specificity scores.


In the preliminary analysis, intra-operator reproducibility of SWE size (R ≥0.93) and mean elasticity (R = 0.88) measurements were in near-perfect agreement. Using the best three-variable model (BIRADS + elasticity shape + maximum elasticity), the Az increased from 0.77 to 0.93 and specificity increased from 61.8% to 87.3%, although sensitivity decreased from 92.7% to 87.8%. Adding more variables did not effect further improvements.


In this ongoing study, SWE provided reproducible information (elasticity values and SWE mapping) that improved the characterization of breast lesions. These features are directly linked to the characteristics of SWE: local quantification and millimeter resolution. Further evaluation of the study is in progress.

Authors’ Affiliations

Imperial College, Hammersmith Hospital, London, UK
Jean Mermoz Private Hospital, Lyon, France
University Hospital, Frauenklinik, Greifswald, Germany
German Diagnostic Clinic, Wiesbaden, Germany
Yale Medical Center, New Haven, CT, USA
Centre Antoine Lacassagne, Nice, France
Northwestern Memorial Hospital, Chicago, IL, USA
Charing Cross Hospital, London, UK
Centre Antoine Lacassagne, Nice, France
Institut Curie, Paris, France
Sally Jobe Breast Center, Denver, CO, USA
University of Southern California, Los Angeles, CA, USA


© Cosgrove et al; licensee BioMed Central Ltd. 2010

This article is published under license to BioMed Central Ltd.